BMYNYSEPharmaceutical PreparationsFiscal year ends December 31Also trades as CELG.RI

BRISTOL MYERS SQUIBB CO

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Jul 30, 2026

$58.83−0.92 (-1.54%)

Close on Oct 19, 2026

Market cap: $120.48B
P/E (TTM): 13.0
Dividend yield: 4.23%

BRISTOL MYERS SQUIBB CO income statement

Annual Quarterly TTM

Millions of USD, except per-share data. Shares in millions.

Line item	FY 2025 2025-12-31	FY 2024 2024-12-31	FY 2023 2023-12-31	FY 2022 2022-12-31	FY 2021 2021-12-31	FY 2020 2020-12-31	FY 2019 2019-12-31	FY 2018 2018-12-31	FY 2017 2017-12-31	FY 2016 2016-12-31	FY 2015 2015-12-31	FY 2014 2014-12-31	FY 2013 2013-12-31	FY 2012 2012-12-31	FY 2011 2011-12-31	FY 2010 2010-12-31	FY 2009 2009-12-31	FY 2008 2008-12-31	FY 2007 2007-12-31
Revenue	48,194	48,300	45,006	46,159	46,385	42,518	26,145	22,561	20,776	19,427	16,560	15,879	16,385	17,621	21,244	19,484	18,808	17,715	15,617
Cost of Revenue	13,936	13,968	10,693	10,137	9,940	11,773	8,078	6,467	6,014	4,969	3,909	3,932	4,619	4,610	5,598	5,277	5,140	5,316	4,919
Gross Profit	34,258	34,332	34,313	36,022	36,445	30,745	18,067	16,094	14,682	14,481	12,651	11,947	11,766	13,011	15,646	14,207	13,668	12,399	10,698
Research & Development	9,951	11,159	9,299	9,509	10,195	10,048	6,148	6,332	6,468	5,012	5,920	4,534	3,731	3,904	3,839	3,566	3,647	3,512	3,160
Selling, General & Admin	7,267	8,414	7,772	7,814	7,690	7,661	4,871	4,551	4,751	4,979	4,841	4,822	4,939	4,220	4,203	3,686	3,946	4,140	3,941
Advertising Expenses	1,300	1,500	1,400	1,300	1,300	990	633	672	740	789	825	734	855	797	957	977	1,136	1,181	1,097
Total Costs & Expenses	38,866	56,679	36,566	38,446	38,287	49,389	21,170	16,593	15,645	13,512	14,483	13,498	13,494	15,281	14,263	13,413	13,206	12,939	13,094
Interest Expense	1,891	1,947	1,166	1,232	1,334	1,420	656	183	196	167	184	203	199	182	145	145	184	310	–
Interest & Investment Income	586	478	449	171	39	121	464	173	126	97	101	101	104	106	91	75	54	130	–
Income from Equity Investments	47	44	-38	-108	231	72	-85	93	75	77	83	107	166	183	281	313	550	617	524
Other Non-Operating Income	-674	-893	1,158	-576	720	2,314	-938	854	1,685	1,448	187	-210	-205	80	334	93	381	-22	-77
Merger & Restructuring Charges	563	635	365	75	169	530	301	131	293	109	118	163	226	174	116	113	136	215	180
Asset Impairment Charges	–	–	–	–	–	–	–	64	241	13	1.00	13	–	–	–	236	0	349	379
Gain (Loss) on Investments	280	16	-160	-801	745	1,228	170	-530	–	–	–	–	–	–	–	–	–	–	–
Gain (Loss) on Sale of Assets	-1.00	-15	0	211	9.00	55	1,168	178	164	576	194	564	–	–	–	–	367	158	223
Legal Settlements	-434	-84	390	-178	-82	194	-77	-76	487	-47	-159	-23	-20	45	-6.00	2.00	–	–	–
Pretax Income	9,328	-8,379	8,440	7,713	8,098	-6,871	4,975	5,968	5,131	5,915	2,077	2,381	2,891	2,340	6,981	6,071	5,602	4,776	2,523
Income Tax Expense	2,272	554	400	1,368	1,084	2,124	1,515	1,021	4,156	1,408	446	352	311	-161	1,721	1,558	1,182	1,090	471
Income from Continuing Operations	–	–	–	–	–	–	–	–	–	–	–	–	–	–	3,709	3,102	3,239	2,697	1,296
Income from Discontinued Operations	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	7,442	2,557	876
Net Income incl. Noncontrolling Interests	7,055	-8,933	8,040	6,345	7,014	-8,995	3,460	4,947	975	4,507	1,631	2,029	2,580	2,501	5,260	4,513	11,862	6,243	2,928
Minority Interest in Earnings	–	–	–	18	20	20	21	27	-32	50	66	25	17	541	1,551	1,411	1,250	996	763
Net Income	7,054	-8,948	8,025	6,327	6,994	-9,015	3,439	4,920	1,007	4,457	1,565	2,004	2,563	1,960	3,709	3,102	10,612	5,247	2,165
Net Income to Common	–	–	–	–	–	–	–	–	–	–	–	2,004	2,563	1,959	3,701	3,090	10,552	–	–
EPS (Basic)(per share)	3.47	-4.41	3.88	2.97	3.15	-3.99	2.02	3.01	0.61	2.67	0.94	1.21	1.56	1.17	2.18	1.80	5.35	2.64	1.09
EPS (Diluted)(per share)	3.46	-4.41	3.86	2.95	3.12	-3.99	2.01	3.01	0.61	2.65	0.93	1.20	1.54	1.16	2.16	1.79	5.34	2.62	1.09
Shares Outstanding (Basic, Weighted)(shares)	2,034	2,027	2,069	2,130	2,221	2,258	1,705	1,633	1,645	1,671	1,667	1,657	1,644	1,670	1,700	1,713	1,974	–	–
Shares Outstanding (Diluted, Weighted)(shares)	2,039	2,027	2,078	2,146	2,245	2,258	1,712	1,637	1,652	1,680	1,679	1,670	1,662	1,688	1,717	1,727	1,978	–	–
Dividend per Share(per share)	2.49	2.42	2.31	2.19	2.01	1.84	1.68	1.61	1.57	1.53	1.49	1.45	1.41	1.37	1.33	1.29	1.25	1.24	1.15

Italic numbers are calculated by StockData (for example Q4 = full year − nine months). Per-share data and share counts are adjusted for stock splits. Hover a number for its source; click it to open the filing on SEC.gov. Click a row to chart it.

Ratios

Latest available, balances at Jun 30, 2026

Profitability, TTM

Gross margin: 70.2%
Operating margin: –
Net margin: 18.9%
Return on equity, FY2025: 40.5%

Financial strength

Current ratio: 1.53
Debt to equity: 1.93
Debt to assets: 49.2%
Cash to current liabilities: 46.7%

Valuation

P/E ratio: 13.0
Price to sales: 2.45
Price to book: 5.40
Dividend yield: 4.23%